Latest News

naloxone
OX124 for Opioid Overdose Reversal Receives FDA Complete Response Letter

July 18th 2024

The FDA has issued a complete response letter to Orexo for OX124, a high-dose naloxone nasal spray for opioid overdose reversal.

research
Alcohol Use Disorder Research Roundup: July 11, 2024

July 11th 2024

polypharmacy
Becoming Comfortable With Discomfort: Polypharmacy for Patients With Substance Use Disorders

July 10th 2024

spray can
Unmasking the Hidden Dangers: Office Duster Abuse as an Example of Inhalant Use Disorder

July 3rd 2024

An expert discusses this comorbidity, plus the effects of semaglutide and other GLP-1 agonists on this patient population.
A Look at the Comorbidity of Eating Disorders and Addiction

June 24th 2024

Latest CME Events & Activities

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

PER® Psychiatry Summit

November 7, 2024

View More

5th Annual International Congress on the Future of Neurology®

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

More News

© 2024 MJH Life Sciences

All rights reserved.